Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wineke Armbrust

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
RMD Open|August 14, 2024
More severe parotid gland histopathology in paediatric-onset than in adult-onset Sjögren's diseaseGeertje Elizabeth Legger, Uzma Nakshbandi, Martha S van Ginkel, et al.
Pediatric Rheumatology Online Journal|July 23, 2022
Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritisLuiza R Grazziotin, Gillian Currie, Marinka Twilt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2025
Impact of Interleukin-1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification CriteriaRemco G A Erkens, Greta Rogani, Laura Huber, et al.
Rheumatology (Oxford, England)|August 13, 2021
Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment responseButsabong Lerkvaleekul, Saskia R Veldkamp, M Marlot van der Wal, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2020
Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile DermatomyositisJudith Wienke, Lauren M Pachman, Gabrielle A Morgan, et al.
Lupus Science & Medicine|February 10, 2022
Nailfold capillary scleroderma pattern may be associated with disease damage in childhood-onset systemic lupus erythematosus: important lessons from longitudinal follow-upDieneke Schonenberg-Meinema, Sandy C Bergkamp, Amara Nassar-Sheikh Rashid, et al.
The Journal of Rheumatology|August 17, 2011
Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010Marieke H Otten, Femke H M Prince, Marinka Twilt, et al.
JAMA|November 8, 2011
Factors associated with treatment response to etanercept in juvenile idiopathic arthritisMarieke H Otten, Femke H M Prince, Wineke Armbrust, et al.
Annals of the Rheumatic Diseases|November 12, 2010
Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?Marieke H Otten, Femke H M Prince, Rebecca Ten Cate, et al.
Pediatric Rheumatology Online Journal|April 8, 2021
Dutch patients, caregivers and healthcare professionals generate first nationwide research agenda for juvenile idiopathic arthritisAnouk Verwoerd, Wineke Armbrust, Katherine Cowan, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
RMD Open|August 14, 2024
More severe parotid gland histopathology in paediatric-onset than in adult-onset Sjögren's diseaseGeertje Elizabeth Legger, Uzma Nakshbandi, Martha S van Ginkel, et al.
Pediatric Rheumatology Online Journal|July 23, 2022
Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritisLuiza R Grazziotin, Gillian Currie, Marinka Twilt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2025
Impact of Interleukin-1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification CriteriaRemco G A Erkens, Greta Rogani, Laura Huber, et al.
Rheumatology (Oxford, England)|August 13, 2021
Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment responseButsabong Lerkvaleekul, Saskia R Veldkamp, M Marlot van der Wal, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2020
Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile DermatomyositisJudith Wienke, Lauren M Pachman, Gabrielle A Morgan, et al.
Lupus Science & Medicine|February 10, 2022
Nailfold capillary scleroderma pattern may be associated with disease damage in childhood-onset systemic lupus erythematosus: important lessons from longitudinal follow-upDieneke Schonenberg-Meinema, Sandy C Bergkamp, Amara Nassar-Sheikh Rashid, et al.
The Journal of Rheumatology|August 17, 2011
Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010Marieke H Otten, Femke H M Prince, Marinka Twilt, et al.
JAMA|November 8, 2011
Factors associated with treatment response to etanercept in juvenile idiopathic arthritisMarieke H Otten, Femke H M Prince, Wineke Armbrust, et al.
Annals of the Rheumatic Diseases|November 12, 2010
Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?Marieke H Otten, Femke H M Prince, Rebecca Ten Cate, et al.
Pediatric Rheumatology Online Journal|April 8, 2021
Dutch patients, caregivers and healthcare professionals generate first nationwide research agenda for juvenile idiopathic arthritisAnouk Verwoerd, Wineke Armbrust, Katherine Cowan, et al.
Pageof 5